Artificial intelligence is transforming how researchers work with pathology, biospecimens, and preclinical models. In this webinar, three experts share practical applications of AI from quantitative image analysis to leveraging curated data and optimizing tumor model selection.
Beyond Human Eyes: How AI Turned Routine H&Es from Qualitative to Quantitative Insights
Meredith OsbornAssociate Director Product Management, Discovery Life Sciences
Pathology H&E slides have a long history as a rich source of qualitative data used in both the clinical and research settings to better understand patients' pathology. However, our ability to generate quantitative data from these slides has been limited. Advances in targeted AI algorithms have created the potential to shift from small-cohort qualitative observations to large-scale quantitative data, empowering increased scalability and deeper insights. Examples of targeted AI use will include precise tumor percent evaluations, tumor-infiltrating lymphocyte cell counts, and identification of novel predicative biomarkers.
Unlocking Precision Medicine with Visionaire: 30+ Years of Curated Biospecimen Data
Daryl WaggottDirector - Biologics, Data Products, BioIVT
This presentation explores how BioIVT's decades of experience in biospecimen collection and curation are being used to support advancements in drug discovery and development. The presentation will delve into the unparalleled value of combining clinical, sociodemographic, and biospecimen data to support workflows integrating artificial intelligence. Learn how Visionaire packages this data into actionable insights that empower researchers to accelerate breakthroughs in oncology, neurodegenerative diseases, and beyond.
CertisOI Assistant - Optimizing Preclinical Cancer Model Selection with Agentic AI
Luke JervisSenior Software Engineer, Certis Oncology
Preclinical oncology researchers often struggle with identifying the most suitable tumor models due to limitations in traditional search platforms. This talk introduces CertisOI Assistant, an AI-powered platform that supports researchers with natural language queries, dynamic model selection, and predictive analytics. By integrating proprietary PDX models with the Cancer Cell Line Encyclopedia (CCLE) and the CertisAI predictive intelligence platform, the tool allows researchers to search, refine, and visualize preclinical model selections in real time. The assistant supports exploratory research by generating targeted queries, running Python-based analyses, and producing interactive outputs—all while preserving security and privacy. This presentation will demonstrate how CertisOI Assistant enhances translational efficiency and early decision-making in oncology research.
Presenters
Meredith Osborn
Meredith Osborn, MS, is a biospecimen expert with over 15 years of experience in FFPE biobanking and other biospecimen solutions. As Associate Director of Product Management, she leads strategic initiatives to develop innovative products, meet research needs, and drive thought leadership in the field.
Daryl Waggott
Daryl Waggott is a pioneering force at the intersection of genomics, digital health, and AI-driven physiology. Daryl’s role at BioIVT is to help develop new data products that leverage the rich history of biospecimens. Data products include longitudinal disease collections, regulatory specific data sets and services. Previously, Daryl served as Director of Data Strategy and Technology Programs at Genome Canada, where he advanced national initiatives in precision medicine and federated data governance. His academic journey includes roles at Stanford University, where he contributed to groundbreaking projects integrating genomics and wearable data into next-generation electronic health records. With over 11,000 citations to his name, Daryl’s research spans statistical genetics, machine learning, and mobile health. His work continues to shape the future of individualized healthcare and performance science.
Luke Jervis
Luke Jervis is a software engineer and lead developer of the CertisOI Assistant™, an AI-powered research platform at Certis Oncology Intelligence. With a background in full-stack development and AI system integration, he has played a key role in transforming how researchers interact with complex oncology datasets through intuitive and secure AI tools.
Sponsor
Discovery Life Sciences
BioIVT
Certis Oncology Solutions, Inc.
Content Partners
Scientist.com
Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.
We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.
Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.
